Shots:
Manifold has entered into a strategic research collaboration & licensing deal with Roche to develop multiple next-gen blood-brain barrier (BBB) shuttles for neurological & neurodegenerative diseases, leveraging Manifold’s shuttle portfolio & mDesign AI-driven in vivo discovery platform
As per the deal, Manifold will lead research & discovery of BBB shuttles for Roche’s therapeutic payloads,…
